{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:23:53Z","timestamp":1772756633621,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/ki.2013.406","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T17:27:24Z","timestamp":1396027644000},"page":"745-747","source":"Crossref","is-referenced-by-count":4,"title":["The perils of clinical trials"],"prefix":"10.1016","volume":"85","author":[{"given":"Richard E.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.406_bb0010","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.clinthera.2009.10.020","article-title":"Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States","volume":"31","author":"Koro","year":"2009","journal-title":"Clin Ther"},{"key":"10.1038\/ki.2013.406_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/17425255.2013.777428","article-title":"Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease","volume":"9","author":"Scheen","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 1","key":"10.1038\/ki.2013.406_bb0020","first-page":"S1","article-title":"Canadian Diabetes Association Clinical Practice Guidelines","volume":"37","author":"Committees CPG","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1038\/ki.2013.406_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2013.356","article-title":"Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control","volume":"85","author":"Kohan","year":"2014","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.406_bb0030","series-title":"Brenner and Rector\u2019s The Kidney","first-page":"252","article-title":"Renal handling of organic solutes","author":"Moe","year":"2012"},{"key":"10.1038\/ki.2013.406_bb0035","doi-asserted-by":"crossref","first-page":"e30555","DOI":"10.1371\/journal.pone.0030555","article-title":"Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One [online]"},{"key":"10.1038\/ki.2013.406_bb0040","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(10)60407-2","article-title":"Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Bailey","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.406_bb0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.12090","article-title":"Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease","volume":"15","author":"Yale","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"10.1038\/ki.2013.406_bb0050","first-page":"1104","article-title":"Empagliflozin in patients with type 2 diabetes mellitus (T2DM) and renal impairment (RI)","volume":"62","author":"Barnett","year":"2013","journal-title":"Diabetes"},{"key":"10.1038\/ki.2013.406_bb0055","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1152\/ajpregu.00357.2011","article-title":"Miracle C et al. Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat","volume":"302","author":"Thomson","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815562832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815562832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T09:28:52Z","timestamp":1538731732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815562832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0085253815562832"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.406","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}